NCT06773910 2026-02-27
TIGOS-LS
SCRI Development Innovations, LLC
Phase 2 Recruiting
Clinical Trials
8 trialsNCT06943235 2026-02-11
Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)
Fudan University
Phase 2 Recruiting
NCT06978153 2025-05-18
This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer
Tang-Du Hospital
Phase 2 Not yet recruiting
NCT05443646 2024-05-07
Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT05942508 2023-07-12
A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy
Shandong Cancer Hospital and Institute
Phase 1 Unknown
NCT05483543 2022-08-02
Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy
Fudan University
Phase 2 Unknown
NCT05034133 2021-09-05
Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
Beijing Haidian Hospital
Phase 2 Unknown
NCT04829708 2021-04-29
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy
Shandong Cancer Hospital and Institute
Phase 3 Recruiting